Abstract

Aim . To assess the condition of adhesion function of endothelium in various clinical variants of primary mitral valve prolapse (MVP). Material and methods. Totally, 91 patient studied with primary MVP at the age 21 (19-24) y. First grade mitral regurgitation was found in 45,1% and II — in 54,9% patients. MVP was solitary variant (6,6%) and comorbid with 1-3 minor anomalies of the heart (93,4%). Doppler-echocardiography was done on Vivid07 equipment (Israel). The grade of systemic involvement of connective tissue was 2 (1,5-4,0) points. Controls were 10 healthy persons, matched by age, sex, smoking, body mass index. By the immune enzyme method we checked plasmatic concentrations of L-, E-, Р-selectins, ICAM-1, VCAM-1, PECAM-1 (Bender MedSystems GmbH, Austria). Findings are presented as mediana (25-75 percentiles). Results . In MVP patients the levels of Е-selectin — 43,0 (33,7-54,8) ng/ mL, ICAM-1 — 669,9 (546,4-883,3) ng/mL and VCAM-1 — 925,0 (707,5- 1215,0) ng/mL, were significantly higher, and the level of РЕСАМ-1 — 49,8 (40,4-63,2) ng/mL, in opposite, lower than in control group. L- and P-selectins levels in MVP group were measured as relevant to controls values (p>0,05). In regurgitation cases of II degree, the level of E-selectin and ICAM-1 were maximal (p<0,05). Values of VCAM-1 in MVP patients independently from degree of regurgitation were significantly higher than controls values. There was moderate direst relation of the quantity of minor heart anomalies and level of ICAM-1 (rs=+0,30, р<0,05). In MVP group with increased E-selectin significantly higher was aorta diameter at the level of Valsalva sinuses — 2,5 (2,3-2,7) cm, than in PMV without increased E-selectin level — 2,3 (2,2-2,5) cm (р<0,05). Conclusion . In patients with primary MVP there is an increase of circulating concentrations of E-selectin, ICAM-1, VCAM-1, that represents the level of adhesion, and witnesses about subclinical endothelial dysfunction. For screening evaluation of severity of adhesion disorders of endothelium in MVP it is important to take into account its hemodynamic significance, multiple minor heart anomalies and data on aorta diameter on the level of Valsalva sinuses.

Highlights

  • Независимо от степени регургитации достоверно превышали контрольные величины

  • In mitral valve prolapse (MVP) patients the levels of Е-selectin — 43,0 (33,7-54,8) ng/ mL, ICAM-1 — 669,9 (546,4-883,3) ng/mL and VCAM-1 — 925,0 (707,51215,0) ng/mL, were significantly higher, and the level of РЕСАМ-1 — 49,8 (40,4-63,2) ng/mL, in opposite, lower than in control group

  • Для скрининговой оценки выраженности нарушений адгезивной функции эндотелия при пролапса митрального клапана (ПМК) необходимо учитывать его гемодинамическую значимость, наличие дополнительных (множественных) малых аномалий сердца и данные о диаметре аорты на уровне синусов Вальсальвы

Read more

Summary

Пролапс митрального клапана

In MVP patients the levels of Е-selectin — 43,0 (33,7-54,8) ng/ mL, ICAM-1 — 669,9 (546,4-883,3) ng/mL and VCAM-1 — 925,0 (707,51215,0) ng/mL, were significantly higher, and the level of РЕСАМ-1 — 49,8 (40,4-63,2) ng/mL, in opposite, lower than in control group. ДСТ — дисплазия соединительной ткани, ИМТ — индекс массы тела, ПМК — пролапс митрального клапана, ICAM-1 — молекула межклеточной адгезии 1 типа, РЕСАМ-1 — тромбоцитарно-эндотелиальная адгезивная молекула 1 типа, VCAM-1 — сосудистая молекула адгезии 1 типа. Принимая во внимание тот факт, что одним из ранних признаков эндотелиальной активности является повышенная экспрессия молекул адгезии, в частности Е-селектина, ICAM-1, VCAM-1 [7], представляется логичным использовать данные о состоянии адгезивной функции эндотелия в качестве скрининга для стратификации пациентов с ПМК. Цель исследования: оценить состояние адгезивной функции эндотелия при различных клинических вариантах первичного ПМК

Материал и методы
Пациенты с ПМК и митральной регургитацией
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call